BLIS Technologies Ltd represents the values of innovation, research excellence, and dedication to improving oral health. With a corporate philosophy focused on developing and commercializing unique probiotic strains, BLIS Technologies aims to provide effective and natural solutions for maintaining oral wellness. Their commitment to pioneering advancements in probiotic technology has allowed them to establish a strong market presence and deliver quality products. By prioritizing customer satisfaction and delivering scientifically proven solutions, BLIS Technologies Ltd has become a trusted name in the industry, continually striving to improve oral health and overall well-being.

BLIS Technologies Ltd is primarily present in New Zealand and Australia.

BLIS Technologies Ltd has achieved several significant milestones. The company pioneered the development of advanced oral probiotics, which have gained recognition worldwide. BLIS has successfully commercialized its proprietary BLIS K12 bacteria strain, which is proven to promote oral health and prevent throat infections. Additionally, BLIS Technologies Ltd has made substantial progress in expanding its product portfolio, introducing innovative oral care solutions for different age groups. With a strong focus on research and development, BLIS continues to advance its probiotics technology, ensuring the delivery of safe and effective products. The company’s commitment to promoting oral health has positioned BLIS Technologies Ltd as a leader in the probiotics industry.

BLIS Technologies Ltd is a renowned company with a rich history and background. Founded in 2000, BLIS Technologies specializes in advanced probiotics research and development. The company focuses on creating innovative oral probiotic products that support oral and upper respiratory health. BLIS Technologies has gained recognition for its groundbreaking work in the field of bacteriocin-producing probiotics. With a team of dedicated researchers and scientists, the company continues to push boundaries and deliver high-quality products that promote overall well-being. BLIS Technologies is committed to staying at the forefront of probiotics technology, improving lives through its science-backed solutions.

The main competitors of BLIS Technologies Ltd in the market include other companies that specialize in probiotics and oral health solutions. Some notable competitors include Probi AB, a Swedish biotechnology company; BioGaia AB, a Swedish healthcare company; and DuPont Nutrition & Biosciences, a global leader in probiotics. These companies offer similar products and services, targeting the same consumer base as BLIS Technologies Ltd.

BLIS Technologies Ltd is primarily active in the health and wellness industry.

BLIS Technologies Ltd. operates on a business model focused on developing and commercializing advanced probiotic products. Specializing in oral probiotics, the company aims to enhance oral health by harnessing the natural antimicrobial properties of certain strains of bacteria. BLIS Technologies Ltd. utilizes cutting-edge research and development to create innovative probiotic formulations. With a primary focus on streptococcus salivarius, their products offer targeted solutions for various oral concerns, including bad breath and sore throats. By leveraging their expertise in probiotics, BLIS Technologies Ltd. aims to improve oral hygiene and overall well-being through their unique business model.

The BLIS Technologies P/E ratio is 43.38.

The BLIS Technologies P/S ratio is 2.43.

The AlleAktien quality score for BLIS Technologies is 3/10.

The BLIS Technologies revenue is 11.53 M NZD.

The BLIS Technologies profit is 646,000 NZD.

BLIS Technologies Ltd is an innovative company specializing in the development of personal oral health care and technologies. The company has two business areas - oral health care and technologies. In the field of oral health care, the company offers a wide range of products that build upon the body's natural defense mechanisms to keep the mouth healthy. BLIS Probiotics is a key player in the market by producing a unique type of probiotic bacteria specifically designed for mouth protection. The company offers BLIS K12 Breath Gum, which contains unique probiotics that target bacterial infections in the oral cavity. These gums reduce tooth decay and combat the causes of halitosis. Another important brand of BLIS is Throat Guard Probiotics. These lozenges are specially formulated to reduce sore throats and upper respiratory infections, and soothe the throat. They are available in various flavors and can be used by adults and children alike. In addition to oral health products, BLIS Technologies also produces technologies for monitoring and analyzing bacterial strains. The company has developed a method for identifying strains of bacteria that often reside in the human body, such as Streptococcus mutans, Lactobacillus fermentum, and Staphylococcus aureus. With this technology, it is possible to obtain real-time information about bacterial strains and analyze their genetic profiles. BLIS Technologies also sells licenses for its technologies to other companies and organizations in the food and beverage industry. These companies can enhance their own products using BLIS technologies and leverage the benefits of probiotics to improve consumer health. The company works closely with customers around the world to develop customized solutions for their specific requirements. Customers form partnerships with BLIS Technologies to enhance their products and promote the health of their customers. Overall, BLIS Technologies is a leading provider of probiotic technologies and oral health products. The company is continuously striving to develop innovative solutions to improve people's health. By producing high-quality probiotics and providing services for monitoring and analyzing bacterial strains, BLIS Technologies has become a significant player in the industry.

BLIS Technologies pays a dividend of 0 NZD distributed over payouts per year.

The dividend cannot currently be calculated for BLIS Technologies or the company does not pay out a dividend.

The ISIN of BLIS Technologies is NZBLTE0002S8.

The WKN of BLIS Technologies is 724615.

The ticker of BLIS Technologies is BLT.NZ.

Over the past 12 months, BLIS Technologies paid a dividend of 0.05 NZD . This corresponds to a dividend yield of about 227.27 %. For the coming 12 months, BLIS Technologies is expected to pay a dividend of 0 NZD.

The current dividend yield of BLIS Technologies is 227.27 %.

BLIS Technologies pays a quarterly dividend. This is distributed in the months of .

BLIS Technologies paid dividends every year for the past 0 years.

For the upcoming 12 months, dividends amounting to 0 NZD are expected. This corresponds to a dividend yield of 0 %.

BLIS Technologies is assigned to the 'Health' sector.

To receive the latest dividend of BLIS Technologies from 11/11/2011 amounting to 0.05 NZD, you needed to have the stock in your portfolio before the ex-date on 11/4/2011.

The last dividend was paid out on 11/11/2011.

In the year 2023, BLIS Technologies distributed 0 NZD as dividends.

The dividends of BLIS Technologies are distributed in NZD.